Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After Chemotherapy

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2024
To evaluate the efficacy, safety, and immunogenicity of PEG-G-CSF Injection (Kexing Biopharmaceutical Co., Ltd.) for the prevention of neutropenia after chemotherapy, using the PEG-G-CSF Injection ( Neulasta®, Amgen Europe B.V.) as a positive control.
Epistemonikos ID: feb4d4d78ca6e59b59fd14081b120a46560a43b5
First added on: Apr 17, 2025